glp 1 for cardiovascular health Glucagon-like peptide receptor agonists: benefits and mechanisms of action Cardiovascular benefits of glucagon-like peptide-1

[1] [2] The medication works by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion in response to elevated blood glucose levels, suppresses glucagon release, and slows gastric emptying

In his latest work Gellman has started to examine more closely how the membrane-anchored receptors engage with these drugs

But they also, in fact, reduce some of the risk in the brain

305 Strikingly, GSIS and oral glucose tolerance were normal in these mice, and GLP-1 levels were not altered but interestingly GIP levels were decreased

Compared with individuals in the metformin and second- or third-line glucose-lowering medications groups, major CVEs were significantly lower in individuals with NAFLD and type 2 diabetes who received GLP-1RAs but not different from those who received SGLT2 inhibitors